These innovative treatments, Tirzepatide , represent a significant advancement in addressing metabolic dysfunction and possibly related conditions . They all are classified as GLP-1 pathway https://montyirkx301783.idblogz.com/41738104/retatrutide-a-thorough-dive-into-incretin-agents